CDH17 and gastric cancer: In the present study, D2101 was radiolabeled with 111In (111In-D2101), and the pharmacokinetics of 1111In-D2101 were evaluated by biodistribution studies in CDH17-positive and CDH17-negative gastric cancer xenograft mice.